ERBB2 and neoplasm: According to Qi Luo et al., a correlation exists between the immunohistochemical expression of COL11A1 and conventional markers (ER, PR, HER2), as well as with clinical parameters including primary tumor grade (T), number of affected lymph nodes (N), and the presence or absence of distant metastases (M).